Why You Should Support the Conference
This conference is the premier event dedicated to bringing practicing clinicians across all 50 states together with leading experts in cancer genomics to learn about the latest in precision cancer risk assessment and targeted therapeutics. As a sponsor of the 2023 conference, you will have a unique opportunity to build awareness and network with a wide cross-section of clinicians providing oncology care in diverse practice settings across the U.S., and internationally-recognized leaders at the forefront of integrating cancer genomics discovery into clinical care.
Exhibit space is available to companies interested in participating in this conference through exhibition, on a first-come first-served basis.
Exhibitor and Sponsorship Prospectus:
Click Here
Exhibitor/Sponsor Application:
Click Here
For more information, please contact [email protected] to discuss customized sponsorship packages!
The Division of Clinical Cancer Genomics thanks its committees for their volunteer efforts and for making this event possible.
We gratefully acknowledge the growing list of sponsors and exhibitors for the 11th Annual Clinical Cancer Genomics and Genetics Conference - From Precision Medicine to Precision Prevention: Joining Forces Across the Spectrum of Care.
These industry leaders make it possible to bring the latest in evidence-based advanced in cancer genomics and precision medicine to clinicians in diverse practices across the U.S. and around the world.
SPONSORS
PLATINUM
AstraZeneca Pharmaceuticals
SILVER
Exact Sciences
EXHIBITORS
 Astellas Oncology |
 Ambry Genetics |
BAYER |
 FamGenix |
Foundation Medicine |
 GRAIL |
 Invitae |
 Immunovia, Inc. |
 Myriad |
 National Consortium of Breast Centers |
 Recursion |
 Sanofi |
 TEMPUS LABS, INC. |